Elevance Health Inc [ELV] stock is trading at $411.24, up 2.56%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ELV shares have gain 6.74% over the last week, with a monthly amount glided 10.88%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Elevance Health Inc [NYSE: ELV] stock has seen the most recent analyst activity on January 22, 2025, when Stephens downgraded its rating to a Equal-Weight and also revised its price target to $440 from $520. Previously, Argus downgraded its rating to Hold on October 18, 2024. On July 18, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $530 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $643 on June 24, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $649 as its price target on May 30, 2024. Barclays started tracking with a Overweight rating for this stock on March 06, 2024, and assigned it a price target of $584. In a note dated July 12, 2023, Wolfe Research downgraded an Peer Perform rating on this stock.
Elevance Health Inc [ELV] stock has fluctuated between $362.21 and $567.26 over the past year. Currently, Wall Street analysts expect the stock to reach $525.33 within the next 12 months. Elevance Health Inc [NYSE: ELV] shares were valued at $411.24 at the most recent close of the market. An investor can expect a potential return of 27.74% based on the average ELV price forecast.
Analyzing the ELV fundamentals
Elevance Health Inc [NYSE:ELV] reported sales of 176.81B for the trailing twelve months, which represents a growth of 6.55%. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.14 and Total Capital is 0.56. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 405.17 points at the first support level, and at 399.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 416.40, and for the 2nd resistance point, it is at 421.56.
Ratios To Look Out For
For context, Elevance Health Inc’s Current Ratio is 1.45. Considering the valuation of this stock, the price to sales ratio is 0.54, the price to book ratio is 2.18 and price to earnings (TTM) ratio is 16.06.
Transactions by insiders
Recent insider trading involved Kendrick Charles Morgan JR, EVP & President, Commercial, that happened on Oct 18 ’24 when 7417.0 shares were sold. Director, Kendrick Charles Morgan JR completed a deal on Oct 18 ’24 to buy 7417.0 shares. Meanwhile, Director PERU RAMIRO G sold 753.0 shares on Aug 05 ’24.
